The latest investor preso (see here) warns shareholders of supply chain issues -- increased raw materials and transport costs, semiconductor shortages -- and says that management expect these pressure to last for the remainder of FY22, and possibly beyond.

This will impact margins, and has prompted the company to build up inventory. The business will also be investing in added sales resources. With $7m in cash, they are also on the lookout for acquisitions, particularly in Europe and the US.

Will be interesting to see how sustained these supply chain issues are, and whether there is much capacity to increases prices (i suspect not)

I think there's good scope for sales growth as they prosecute their record order book, but with ongoing investment and added costs it'll make profit growth more difficult.

Austco has won a $3.3m contract to supply its Tacera Nurse call platform to Khoo Teck Puat Hospital -- a 795 bed hospital in Singapore (as a side note, Singapore has one of the worlds leading healthcare systems. Certainly in the top 5 globally).

ASX announcement here

The deal is a significant one, representing ~10% of last years total revenue. 

Further, the hospital belongs to the Yishun Health Network -- and it is Yishun that the contract is with. This network encompases many other healthcrae institutions in Singapore, so although it wasnt mentioned, I assume there's potential for the contract to be extended to other facilities if all goes well.